The Requirements Checklist to Get Ferriprox (deferiprone) Covered by Aetna (CVS Health) in Virginia
Answer Box: Your Path to Ferriprox Coverage
To get Ferriprox (deferiprone) covered by Aetna (CVS Health) in Virginia: Submit prior authorization through CVS Caremark with documented transfusional iron overload (ferritin >1,000 mcg/L), prescribed by a hematologist for patients ≥8 years with thalassemia or sickle cell disease. If denied, appeal within 60 days, then file external review with Virginia's Bureau of Insurance using Form 216-A within 120 days. Start today: Call Aetna at 1-800-AETNA66 for PA forms and confirm your plan's specialty pharmacy requirements.
Table of Contents
- Who Should Use This Checklist
- Member & Plan Basics
- Clinical Criteria Requirements
- Coding & Documentation
- Submission Process
- Specialty Pharmacy Routing
- After Submission: What to Expect
- Appeals Process in Virginia
- Common Denial Reasons & Prevention
- Printable Checklist
Who Should Use This Checklist
This guide is for Virginia patients with transfusional iron overload from conditions like thalassemia or sickle cell disease who need Ferriprox (deferiprone) covered by Aetna (CVS Health). You'll also find this helpful if you're a clinician submitting prior authorization requests or appealing denials for this oral iron chelator.
Expected outcome: Following this checklist increases your chances of first-time approval and provides a clear roadmap if you face a denial. Ferriprox costs approximately $7,543 for a 50-tablet supply without insurance, making coverage essential for most patients.
Member & Plan Basics
Verify Your Coverage Status
Before starting, confirm these basics:
- Active Aetna (CVS Health) coverage with current member ID
- Plan type: Commercial, Medicare Advantage, or Medicaid managed care
- Deductible status: Whether you've met annual deductible requirements
- Specialty pharmacy benefit: Most Aetna plans require CVS Specialty for Ferriprox
Tip: Call the member services number on your insurance card to verify Ferriprox is covered under your specific plan and confirm any formulary restrictions.
Clinical Criteria Requirements
FDA-Approved Indication
Ferriprox is FDA-approved for transfusional iron overload in patients with thalassemia syndromes when current chelation therapy is inadequate. Off-label use for sickle cell disease and other anemias may require additional documentation.
Aetna's Coverage Criteria
| Requirement | Documentation Needed | Source |
|---|---|---|
| Age ≥8 years (tablets) or ≥3 years (oral solution) | Birth certificate or medical record | CVS Specialty PA Guide |
| Serum ferritin >1,000 mcg/L | Lab results within 90 days | Aetna Policy |
| Transfusional iron overload diagnosis | Transfusion records, clinical notes | CVS PA Requirements |
| Hematologist involvement | Prescription or consultation note | Standard PA Criteria |
| ANC monitoring plan | Provider attestation for neutrophil monitoring | FDA Label Warning |
Step Therapy Considerations
Most Aetna plans require documentation that first-line chelators (like deferoxamine) have failed, caused intolerance, or are contraindicated. Document:
- Previous chelation attempts with dates and outcomes
- Reasons for discontinuation (side effects, non-compliance, ineffectiveness)
- Clinical rationale for Ferriprox specifically
Coding & Documentation
Essential ICD-10 Codes
- Primary: E83.111 (Hemochromatosis due to repeated red blood cell transfusions)
- Supporting: D56.0-D56.9 (Thalassemia), D57.1-D57.2 (Sickle cell disease)
HCPCS/Billing Information
- J-Code: J1443 (Injection, deferiprone, 1 mg) for billing purposes
- NDC: Various based on strength and formulation
- Modifiers: May include JA (chelation drug) or TA (pediatric)
Medical Necessity Letter Components
Your hematologist's letter should include:
- Patient demographics and insurance information
- Specific diagnosis with ICD-10 codes
- Transfusion history (≥100 mL/kg packed RBCs annually)
- Current ferritin levels and trend over time
- Previous chelation attempts and failures
- Dosing plan (typically 75-99 mg/kg/day divided)
- Monitoring protocol for neutrophil counts
- Treatment duration and expected outcomes
Submission Process
Required Forms and Portals
- Primary submission: CVS Caremark Provider Portal or Aetna provider portal
- Alternative: Fax to CVS Specialty at 1-800-294-3850
- Required forms: Complete PA request with all supporting documentation
Document Checklist
Before submitting, gather:
- Completed prior authorization form
- Medical necessity letter from hematologist
- Recent lab results (ferritin, complete blood count)
- Transfusion records for past 12-24 months
- Documentation of previous chelation therapy attempts
- Patient insurance card copy
- Prescriber NPI and contact information
Submission Timeline
- Standard review: 24-72 hours for most requests
- Expedited review: 24 hours for urgent medical needs
- Follow-up: Check status within 3-5 business days
Specialty Pharmacy Routing
CVS Specialty Requirements
Aetna typically requires Ferriprox to be dispensed through CVS Specialty. Key steps:
- Enrollment: Patient must enroll with CVS Specialty
- Prescription transfer: From retail pharmacy if needed
- Prior authorization: Must be approved before dispensing
- Shipping verification: Confirm delivery address and timing
- Refill coordination: Set up automatic refills if appropriate
Note: Write "Dispense as written" on prescriptions if brand-name Ferriprox is medically necessary over generic alternatives.
After Submission: What to Expect
Confirmation and Tracking
- Confirmation number: Save for all future reference
- Status checks: Every 3-5 business days via portal or phone
- Documentation: Keep records of all communications
Approval Timeline
| Review Type | Expected Timeline | Next Steps |
|---|---|---|
| Standard PA | 24-72 hours | CVS Specialty contacts patient for enrollment |
| Expedited PA | 24 hours | Immediate processing for urgent cases |
| Additional information needed | 5-10 business days | Respond promptly to avoid delays |
Appeals Process in Virginia
Internal Appeals with Aetna
If your initial request is denied:
- Timeline: File within 60 days of denial notice
- Method: Online portal, phone (1-800-AETNA66), or written appeal
- Documentation: Include new evidence, peer-reviewed studies, clinical guidelines
- Review time: 30 days standard, 72 hours for expedited appeals
External Review through Virginia SCC
Virginia provides robust external review rights through the State Corporation Commission Bureau of Insurance:
Filing Requirements
- Form: Form 216-A External Review Request
- Deadline: Within 120 days of Aetna's final internal denial
- Submission: Mail to SCC Bureau of Insurance, P.O. Box 1157, Richmond, VA 23218
- Contact: 1-877-310-6560 or [email protected]
Process Timeline
- Standard external review: 45 days for decision
- Expedited review: 72 hours for urgent cases (requires physician certification)
- Cost: Free to patients
- Decision: Binding on Aetna if overturned
Virginia Advantage: The state's external review process is particularly patient-friendly, with independent medical experts reviewing denials and strong enforcement of favorable decisions.
Common Denial Reasons & Prevention
Top 5 Denial Reasons and Solutions
| Denial Reason | Prevention Strategy | Required Documentation |
|---|---|---|
| Insufficient ferritin documentation | Submit recent labs showing >1,000 mcg/L | Lab results within 90 days |
| Missing step therapy | Document previous chelator failures | Treatment records, side effect notes |
| Age requirements not met | Verify patient ≥8 years for tablets | Birth certificate or medical record |
| No hematologist involvement | Ensure specialist prescription or consultation | Referral letter or specialist note |
| Incomplete monitoring plan | Detail ANC monitoring protocol | Provider attestation for safety monitoring |
Proactive Tips
- Double-check forms: Ensure all required fields are completed
- Include excess documentation: Better to provide too much than too little
- Follow up promptly: Respond to requests for additional information immediately
- Keep detailed records: Document all phone calls and correspondence
From Our Advocates
"We've seen Virginia patients succeed with Ferriprox appeals by emphasizing the state's strong external review process in their initial submissions. When Aetna knows that Virginia's Bureau of Insurance will independently review any denial with fresh medical eyes, they often approve cases that might be denied elsewhere. The key is thorough documentation from the start and knowing your rights under Virginia law."
Printable Checklist
Before You Start
- Verify active Aetna (CVS Health) coverage
- Confirm specialty pharmacy requirements
- Gather insurance cards and member information
Clinical Documentation
- Diagnosis: Transfusional iron overload (ICD-10: E83.111)
- Age verification: ≥8 years (tablets) or ≥3 years (solution)
- Ferritin level: >1,000 mcg/L (recent lab results)
- Transfusion records: ≥100 mL/kg/year documentation
- Hematologist involvement: Prescription or consultation
- Previous chelation attempts: Documented failures/intolerance
- Monitoring plan: ANC safety protocol established
Submission Requirements
- Complete PA form via CVS Caremark portal
- Medical necessity letter from specialist
- All supporting lab results and records
- Prescriber NPI and contact information
- Patient enrollment with CVS Specialty initiated
Post-Submission
- Confirmation number recorded
- Status check scheduled (3-5 days)
- Appeal timeline noted (60 days if denied)
- Virginia external review option confirmed (120 days)
Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals with the right medical evidence and procedural requirements. We understand that getting specialty medications like Ferriprox covered shouldn't require navigating complex insurance bureaucracy alone.
For additional support with your Ferriprox coverage journey, visit Counterforce Health to learn how our platform can help streamline your appeal process and improve your chances of approval.
Sources & Further Reading
- Aetna Ferriprox Policy 2024
- CVS Specialty Prior Authorization Guide
- FDA Ferriprox Label
- Virginia SCC External Review Process
- Virginia Form 216-A
- Chiesi Total Care Support
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and may change. Always verify current requirements with your insurance provider and consult your healthcare team for medical decisions. For personalized assistance with Virginia insurance appeals, contact the SCC Bureau of Insurance at 1-877-310-6560.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.